Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
NeoGenomics, Inc. - Common Stock
(NQ:
NEO
)
9.890
-0.120 (-1.20%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about NeoGenomics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
December 28, 2023
Via
Benzinga
NeoGenomics, Energy Fuels And Other Big Stocks Moving Lower On Thursday
↗
December 28, 2023
U.S. stocks traded higher, with the Dow Jones index gaining around 80 points on Thursday. Shares of NeoGenomics, Inc. (NASDAQ: NEO) shares fell sharply during Thursday’s session after Natera won a...
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Stocks
7 Analysts Have This To Say About NeoGenomics
↗
December 28, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About NeoGenomics
↗
November 07, 2023
Via
Benzinga
Earnings Scheduled For November 6, 2023
↗
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
Bull Of The Day: NeoGenomics
↗
October 24, 2023
NeoGenomics is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer.
Via
Talk Markets
Where NeoGenomics Stands With Analysts
↗
October 16, 2023
Via
Benzinga
4 Analysts Have This to Say About NeoGenomics
↗
August 21, 2023
Via
Benzinga
NeoGenomics Raises Annual Guidance After Solid Q2 Earnings Beat
↗
August 08, 2023
NeoGenomics, Inc. (NASDAQ: NEO) reported Q2 revenues of $146.92 million, +18% Y/Y, beating the
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
↗
September 08, 2023
Via
Benzinga
Earnings Scheduled For August 11, 2023
↗
August 11, 2023
Companies Reporting Before The Bell • Consolidated Water Co (NASDAQ:CWCO) is estimated to report quarterly earnings at $0.22 per share on revenue of $30.27 million.
Via
Benzinga
Guardant Health Stock Reaches 80-Plus Relative Strength Rating Benchmark
↗
June 23, 2023
On Friday, Guardant Health stock hit a key performance benchmark, with its Relative Strength Rating rising to 82, up from 78 the day before.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
↗
May 16, 2023
Via
Benzinga
NeoGenomics's Return On Capital Employed Insights
↗
May 15, 2023
Via
Benzinga
NeoGenomics: Q1 Earnings Insights
↗
May 12, 2023
Via
Benzinga
Earnings Scheduled For May 12, 2023
↗
May 12, 2023
Companies Reporting Before The Bell • Honda Motor Co (NYSE:HMC) is expected to report earnings for its fourth quarter.
Via
Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
May 09, 2023
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
Via
Benzinga
NeoGenomics Reports Q1 Topline Growth, Lifts Annual Guidance, Shares Soar
↗
May 09, 2023
NeoGenomics Inc (NASDAQ: NEO) reported Q1 revenues of $137.22 mill
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023
↗
May 09, 2023
Via
Benzinga
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
↗
May 09, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Analyst Expectations for NeoGenomics's Future
↗
May 09, 2023
Via
Benzinga
What 9 Analyst Ratings Have To Say About NeoGenomics
↗
April 11, 2023
Via
Benzinga
Looking Into NeoGenomics's Return On Capital Employed
↗
March 30, 2023
Via
Benzinga
Analyst Ratings for NeoGenomics
↗
March 03, 2023
Via
Benzinga
Cowen & Co. Maintains Outperform Rating for NeoGenomics: Here's What You Need To Know
↗
February 24, 2023
Via
Benzinga
3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing
↗
March 19, 2023
The high-flyers have soared to new heights and further gains could be up ahead.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
↗
February 24, 2023
Via
Benzinga
Why Shares of NeoGenomics Jumped Today
↗
February 23, 2023
The company released promising earnings results.
Via
The Motley Fool
Crude Oil Rises 1.5%; NeoGenomics Shares Spike Higher
↗
February 23, 2023
U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded down 0.03% to 33,036.50 while the NASDAQ rose 0.46% to...
Via
Benzinga
Why NeoGenomics Shares Are Trading Higher Today
↗
February 23, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.